STAT+: Pharmalittle: Teva and Merck may help with Covid-19 vaccine production; $5 billion Gilead deal goes up in flames
Good morning, everyone, and how are you today? We are doing just fine, thank you, now that the Pharmalot campus has settled down. Our short person is hunched over a laptop for another round of learning and our official mascot is bounding up and down snow drifts. As for us, we are firing up the coffee kettle for another cup of stimulation. Our choice today is French vanilla, an old standby. Feel free to join us. Remember, no prescription is required, so no need to calculate rebates. Meanwhile, here are some choice tidbits. Hope your day goes well, and stay safe — wear a mask. …
Teva Pharmaceutical (TEVA) is in talks with other drug makers to co-produce some Covid-19 vaccines, Israel Hayom writes. Teva chief executive officer Kare Schultz said the company approached — and was approached by — vaccine makers, but he declined to name the companies with which it was in discussions. “In principle, we are positive towards contributing by manufacturing some of those vaccines that either have been approved or are just about to be approved,” he said.
Continue to STAT+ to read the full story…
